Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Indegene Limited, is an unlisted public company incorporated on 16 October, 1998. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 80.00 cr and the total paid-up capital is INR 47.85 cr.
Indegene Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 5.45% over the previous year. At the same time, it's book networth has increased by 22.35%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Jairaj Manohar Purandare
Shareholder
|
00159886 | 3 years |
Director | Rajesh Bhaskaran Nair
Shareholder
|
00219269 | 27 years |
Whole-time Director | Manish Gupta
Shareholder
|
00219273 | 25 years |
CEO | Manish Gupta | <HIDDEN> | 3 years |
Director | Sanjay Suresh Parikh
Shareholder
|
00219278 | 23 years |
Director | Ashish Gupta
Shareholder
|
00521511 | 3 years |
Nominee Director | Mark Dzialga | 00955485 | 4 years |
Nominee Director | Neeraj Bharadwaj | 01314963 | 4 years |
Director | Krishnamurthy Venugopala Tenneti | 01338477 | 17 years |
Director | Pravin Udhyavara Bhadya Rao | 06782450 | 3 years |
CFO | Suhas Prabhu
Shareholder
|
<HIDDEN> | 3 years |
Director | Georgia Nikolakopoulou Papathomas | 09734940 | 3 years |
CS | Srishti Ramesh Kaushik | <HIDDEN> | 15 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 30.5 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 15.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 15.0 cr
BARCLAYS BANK PLC
No. of Loans: 1
Total Amount : 10.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
ILSL Holdings Inc., USA (Formerly Indegene Inc.) | United States | - | - |
Indegene Fareast Pte Ltd, Singapore | Singapore | - | - |
Indegene Lifesystems Consulting (Shanghai) Ltd | China | - | - |
Indegene Europe, LLC | Switzerland | - | - |
Indegene Japan Godo Kaisha (Japan)* | Japan | - | - |
Indegene Healthcare Mexico S DE RL DE CV | Mexico | - | - |
Indegene Inc. | United States | - | - |
Services Indegene Aptilon Inc. | Canada | - | - |
Indegene Ireland Limited | Ireland | - | - |
DT Associates Research and Consulting Services Ltd | United Kingdom | - | - |
DT Associates Research and Consulting Inc. | United States | - | - |
Indegene Healthcare Germany GmbH | Germany | - | - |
Cult Health LLC | United States | - | - |
Indegene Healthcare UK Limited (UK)** | United Kingdom | - | - |
Trilogy Writing & Consulting GmbH (Germany)** | Germany | - | - |
Trilogy Writing & Consulting Limited (UK)** | United Kingdom | - | - |
Trilogy Writing & Consulting Inc. (USA)** | United States | - | - |
Trilogy Writing & Consulting ULC (Canada)** | Canada | - | - |
ILSL Holdings Inc. | United States | - | - |
Indegene Japan Godo Kaisha | Japan | - | - |
Indegene Fareast Pte Ltd | Singapore | - | - |
Indegene Europe LLC | Switzerland | - | - |
Indegene Lifesystems Consulting (Shanghai) Co. Ltd. | China | - | - |
Indegene Healthcare UK Limited | United Kingdom | - | - |
Trilogy Writing & Consulting GmbH | Germany | - | - |
Trilogy Writing & Consulting Limited | United Kingdom | - | - |
Trilogy Writing & Consulting Inc. | United States | - | - |
Trilogy Writing & Consulting ULC | Canada | - | - |
Read more
The incorporation date of INDEGENE LIMITED is 16 October, 1998
The authorized share capital of INDEGENE LIMITED is INR ₹ 80.0 Cr.
The paid-up capital of INDEGENE LIMITED is INR ₹ 47.9 Cr.
The registered address of INDEGENE LIMITED is Aspen G4, 3rd Floor, Manyata Embassy Business Park Outer R ing Road, Nagavara NA Bangalore Bangalore Karnataka - 560045
The CIN number of INDEGENE LIMITED is U73100KA1998PLC102040.